203 related articles for article (PubMed ID: 36455689)
1. Assessing the Prevalence of Financial Toxicity, its Predictors and Association with Health- Related Quality of Life Among Radiation Oncology Patients in India: A Cross-Sectional Patient Reported Outcome Study.
Dar MA; Chauhan R; Trivedi V; Kumar R; Dhingra S
Int J Radiat Oncol Biol Phys; 2023 May; 116(1):157-165. PubMed ID: 36455689
[TBL] [Abstract][Full Text] [Related]
2. Assessing the Financial Toxicity of Radiation Oncology Patients Using the Validated Comprehensive Score for Financial Toxicity as a Patient-Reported Outcome.
D'Rummo KA; Miller L; TenNapel MJ; Shen X
Pract Radiat Oncol; 2020; 10(5):e322-e329. PubMed ID: 31634632
[TBL] [Abstract][Full Text] [Related]
3. Cancer-related financial hardship among head and neck cancer survivors: Risk factors and associations with health-related quality of life.
Lu L; O'Sullivan E; Sharp L
Psychooncology; 2019 Apr; 28(4):863-871. PubMed ID: 30779397
[TBL] [Abstract][Full Text] [Related]
4. Understanding financial toxicity in head and neck cancer survivors.
Mady LJ; Lyu L; Owoc MS; Peddada SD; Thomas TH; Sabik LM; Johnson JT; Nilsen ML
Oral Oncol; 2019 Aug; 95():187-193. PubMed ID: 31345389
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Score for Financial Toxicity and Health-Related Quality of Life in Patients With Cancer and Survivors: A Systematic Review and Meta-Analysis.
Pangestu S; Rencz F
Value Health; 2023 Feb; 26(2):300-316. PubMed ID: 36064514
[TBL] [Abstract][Full Text] [Related]
6. Association of self-reported financial burden with quality of life and oncologic outcomes in head and neck cancer.
Lenze NR; Bensen JT; Farnan L; Sheth S; Zevallos JP; Yarbrough WG; Zanation AM
Head Neck; 2022 Feb; 44(2):412-419. PubMed ID: 34793605
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two validated instruments to measure financial hardship in cancer survivors: comprehensive score for financial toxicity (COST) versus personal financial wellness (PFW) scale.
D'Rummo KA; Nganga D; Chollet-Hinton L; Shen X
Support Care Cancer; 2022 Dec; 31(1):12. PubMed ID: 36513902
[TBL] [Abstract][Full Text] [Related]
8. Patient-Reported Financial Toxicity in a Population-Based Cohort of Oropharynx Cancer Survivors.
Diao K; Lei X; Smith GL; Jagsi R; Peterson SE; Sumer BD; Smith BD; Sher DJ
Int J Radiat Oncol Biol Phys; 2023 May; 116(1):142-153. PubMed ID: 36812043
[TBL] [Abstract][Full Text] [Related]
9. Measuring financial toxicity in Australian cancer patients - Validation of the COmprehensive Score for financial Toxicity (FACT COST) measuring financial toxicity in Australian cancer patients.
Durber K; Halkett GK; McMullen M; Nowak AK
Asia Pac J Clin Oncol; 2021 Aug; 17(4):377-387. PubMed ID: 33567158
[TBL] [Abstract][Full Text] [Related]
10. Validation of Korean Version of the COmprehensive Score for financial Toxicity (COST) Among Breast Cancer Survivors.
Shim S; Kang D; Kim N; Han G; Lim J; Kim H; Park J; Lee M; Lee JE; Kim SW; Yu J; Chae BJ; Ryu JM; Nam SJ; Lee SK; Cho J
Cancer Res Treat; 2022 Jul; 54(3):834-841. PubMed ID: 34645130
[TBL] [Abstract][Full Text] [Related]
11. Patient-Reported Financial Burden of Treatment for Colon or Rectal Cancer.
Kircher S; Duan F; An N; Gareen IF; Sicks JD; Sadigh G; Suga JM; Kehn H; Mehan PT; Bajaj R; Hanson DS; Dalia SM; Acoba JD; Yasar DG; Park ER; Wagner LI; Carlos RC
JAMA Netw Open; 2024 Jan; 7(1):e2350844. PubMed ID: 38194233
[TBL] [Abstract][Full Text] [Related]
12. Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST).
de Souza JA; Yap BJ; Wroblewski K; Blinder V; Araújo FS; Hlubocky FJ; Nicholas LH; O'Connor JM; Brockstein B; Ratain MJ; Daugherty CK; Cella D
Cancer; 2017 Feb; 123(3):476-484. PubMed ID: 27716900
[TBL] [Abstract][Full Text] [Related]
13. Financial toxicity and mental well-being of the oral cancer survivors residing in a developing country in the era of COVID 19 pandemic - A cross-sectional study.
Thaduri A; Garg PK; Malhotra M; Singh MP; Poonia DR; Priya M; Tyagi A; Kumar A; Bhardwaj A; Jat B; Panuganti A; Majumdar K; Usmani S; Vikramjit Singh
Psychooncology; 2023 Jan; 32(1):58-67. PubMed ID: 36073555
[TBL] [Abstract][Full Text] [Related]
14. Financial toxicity and its implication on quality of life in patients attending the palliative care department in a regional cancer centre: An observational study.
Nikte V; Patil S; Chaudhari H; Patil C; Pawar R; Patil P; More H; Katolkar U
J Cancer Policy; 2024 Mar; 39():100460. PubMed ID: 38061493
[TBL] [Abstract][Full Text] [Related]
15. Financial Toxicity in Japanese Patients with Metastatic Renal Cell Carcinoma: A Cross-Sectional Study.
Kimura G; Fujii Y; Honda K; Osawa T; Uchitomi Y; Kondo M; Otani A; Wako T; Kawai D; Mitsuda Y; Sakashita N; Shinohara N
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791981
[TBL] [Abstract][Full Text] [Related]
16. Financial Hardship and Quality of Life among African American and White Cancer Survivors: The Role of Limiting Care Due to Cost.
Hastert TA; Kyko JM; Reed AR; Harper FWK; Beebe-Dimmer JL; Baird TE; Schwartz AG
Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1202-1211. PubMed ID: 31061097
[TBL] [Abstract][Full Text] [Related]
17. Financial toxicity following surgical treatment for colorectal cancer: a cross-sectional study.
Mo M; Jia P; Zhu K; Huang W; Han L; Liu C; Huang X
Support Care Cancer; 2023 Jan; 31(2):110. PubMed ID: 36629938
[TBL] [Abstract][Full Text] [Related]
18. Financial toxicity in patients with gynecologic malignancies: a cross sectional study.
Zeybek B; Webster E; Pogosian N; Tymon-Rosario J; Balch A; Altwerger G; Clark M; Menderes G; Huang G; Azodi M; Ratner ES; Schwartz PE; Santin AD; Andikyan V
J Gynecol Oncol; 2021 Nov; 32(6):e87. PubMed ID: 34431257
[TBL] [Abstract][Full Text] [Related]
19. Assessing the reliability and validity of comprehensive score for financial toxicity (COST) among radiation oncology patients in India: a cross-sectional pilot study.
Dar MA; Chauhan R; Sharma KK; Trivedi V; Dhingra S; Murti K
Ecancermedicalscience; 2021; 15():1219. PubMed ID: 34158823
[TBL] [Abstract][Full Text] [Related]
20. Financial toxicity in gynecologic oncology.
Bouberhan S; Shea M; Kennedy A; Erlinger A; Stack-Dunnbier H; Buss MK; Moss L; Nolan K; Awtrey C; Dalrymple JL; Garrett L; Liu FW; Hacker MR; Esselen KM
Gynecol Oncol; 2019 Jul; 154(1):8-12. PubMed ID: 31053404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
